Approval of active constituents for which information is not readily available
14A Approval of active constituents for which information is not readily available
The APVMA may approve an active constituent for a proposed or existing chemical product if:
either of the following applies:
the APVMA considers that information it requires in respect of the constituent is not readily available;
the constituent is, or is part of, a product in respect of which a standard is specified in the European Pharmacopoeia, the British Pharmacopoeia (Veterinary), the United States Pharmacopeia or any other publication considered by the APVMA to be appropriate; and
having regard to information that is readily available, the APVMA is satisfied that the constituent would meet the safety criteria.
Subsection (1) applies:
despite subsection 14(2); and
whether or not an application has been made for approval of the constituent.
If the APVMA approves an active constituent under this section without an application having been made for the approval, the APVMA must, under paragraph 19(a), be entered in the Record as the holder of the approval.
The statute text is free to read above. View Pro plans to unlock the case-law research tools for each provision.